These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 17065089)
1. Difference in Ki67 and thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients. Calascibetta A; Cabibi D; Rausa L; Aragona F; Barresi E; Martorana A; Sanguedolce R Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1193-6. PubMed ID: 17065089 [TBL] [Abstract][Full Text] [Related]
2. Different expression of thymidylate synthase in primary tumour and metastatic nodes in breast cancer patients. Cabibi D; Calascibetta A; Martorana A; Campione M; Barresi E; Rausa L; Aragona F; Sanguedolce R Anticancer Res; 2007; 27(4B):2227-30. PubMed ID: 17695507 [TBL] [Abstract][Full Text] [Related]
3. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
4. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates. Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662 [TBL] [Abstract][Full Text] [Related]
5. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study. Kawano K; Yanagisawa S; Kusukawa J; Sunagawa H; Shiba R; Goto M; Shinohara M; Fukuda J; Oishi M; Ikemura K; Takahashi T; Sugihara K; Inokuchi T; Mimura T; Goto H Int J Oral Maxillofac Surg; 2006 Mar; 35(3):258-64. PubMed ID: 16280240 [TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase levels as a therapeutic and prognostic predictor in breast cancer. Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H; Fukuda M; Higuchi A; Satoh A; Mizumoto T; Hamamoto R Anticancer Res; 1999; 19(6C):5621-6. PubMed ID: 10697629 [TBL] [Abstract][Full Text] [Related]
7. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents. Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040 [TBL] [Abstract][Full Text] [Related]
8. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer. Okumura K; Mekata E; Shiomi H; Naitoh H; Abe H; Endo Y; Kurumi Y; Tani T Cancer Chemother Pharmacol; 2008 Apr; 61(4):587-94. PubMed ID: 17520254 [TBL] [Abstract][Full Text] [Related]
9. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. Xi Y; Nakajima G; Schmitz JC; Chu E; Ju J BMC Genomics; 2006 Apr; 7():68. PubMed ID: 16584549 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks. Wang W; McLeod HL; Cassidy J; Collie-Duguid ES Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966 [TBL] [Abstract][Full Text] [Related]
11. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma. Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200 [TBL] [Abstract][Full Text] [Related]
12. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer. Fakhrejahani E; Miyamoto A; Tanigawa N Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791 [TBL] [Abstract][Full Text] [Related]
13. Recurrence and 5-FU sensitivity of stage I/II node-negative breast, lung, or gastric cancer with occult neoplastic cells in lymph node sinuses. Mukai M; Sato S; Tajima T; Ninomiya H; Wakui K; Komatsu N; Tsuchiya K; Nakasaki H; Makuuchi H Oncol Rep; 2006 Apr; 15(4):815-20. PubMed ID: 16525664 [TBL] [Abstract][Full Text] [Related]
14. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer. Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355 [TBL] [Abstract][Full Text] [Related]
15. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621 [TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases. Bendardaf R; Elzagheid A; Lamlum H; Algars A; Korkeila E; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S Scand J Gastroenterol; 2007 Apr; 42(4):471-6. PubMed ID: 17454857 [TBL] [Abstract][Full Text] [Related]
17. CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells. Takagi K; Sowa Y; Cevik OM; Nakanishi R; Sakai T Int J Oncol; 2008 May; 32(5):1105-10. PubMed ID: 18425338 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer. Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123 [TBL] [Abstract][Full Text] [Related]
19. Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma? Prall F; Ostwald C; Schiffmann L; Barten M Oncol Rep; 2007 Jul; 18(1):203-9. PubMed ID: 17549369 [TBL] [Abstract][Full Text] [Related]
20. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]